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Abstract 
Lipocalin-2   ( L c n -2) i s   a n   a c u t e -phase protein that has been implicated in diverse physiological 
processes in mice, including: apoptosis, ion transport, inflammation, cell survival, and tumo-
rigenesis. This study characterized the biological activity of Lcn-2   i n   h u m a n   e n d o m e t r i a l   c a r-
cinoma cells (RL95-2). Exposure of RL95-2   c e l l s   t o   L c n -2 for >24 h reduced Lcn-2–induced 
cell apoptosis, changed the cell proliferation and up-regulated cytokine secretions, including: 
interleukin-8  (IL-8),  inteleukin-6  (IL-6),  monocyte  chemotatic  protein-1  (MCP-1)  and 
growth-related oncogene (GRO).   H o w e v e r ,   I L -8 mRNA and protein levels were dramatically 
increased  in  Lcn-2–treated  RL95-2  cells.  To determine the IL-8 effect on Lcn-2-treated 
RL95-2 cells w a s   o u r   m a j o r   f o c u s .   Adding recombinant IL-8 (rIL-8) resulted in decreased 
caspase-3 activity in Lcn-2–treated cells, whereas the addition of IL-8 antibodies resulted in 
significantly increased caspase-3 activity and decreased cell migration. Data indicate that IL-8 
plays a crucial role in the induction of cell migration. Interestingly, Lcn-2-induced cytokines, 
secretion from RL95-2 cells, could not show the potent cell migration ability with the ex-
ception of IL-8. We conclude t h a t   L c n -2 triggered cytokine secretions to prevent RL95-2 cells 
from undergoing apoptosis and subsequently increased cell migration. We hypothesize that 
Lcn-2 increased cytokine secretion by RL95-2 cells, which in turn activated a cellular defense 
system. This study suggests that Lcn-2 may play a role in the human female reproductive 
system or in endometrial cancer. 
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Introduction 
Lipocalins comprise a large and ever-expanding 
g r o u p   o f   p r o t e i n s   t h a t   e x h i b i t   c o n s i d e r a b l e   s t r u c t u r a l  
and  functional  variations,  both  within  and  between 
species [1-4]. Many lipocalins, such  as  PGD2 synthe-
tase, are bi-functional, acting as both an enzyme and a 
retinoid  transporter [5] .   T o   d a t e ,   h o w e v e r ,   t h e   f u n c-
tions of many lipocalins remain unclear. Human neu-
trophil gelatinase-associated lipocalin (hNGAL/24p3) 
i s   a   2 5 -kDa glycoprotein; it has the alternative name 
lipocalin-2 (Lcn-2). Lcn-2 is homologous to a lipocalin 
(24p3) from mice [6] and was first found in the gra-
nules of human neutrophil [7]. Lcn-2 may have simi-
lar functions in different species during  the  estrous 
cycle. The uterine endometrium is responsive   t o   s e x  
s t e r o i d   h o r m o n e s   t h a t   v a r y   i n   a   r e g u l a r   c y c l i c   m a n n e r  
[8].   D u r i n g   t h e   m e n s t r u a l   c y c l e ,   a   r a p i d   s e r i e s   o f   s e-
quences of cellular proliferation, cytokine production 
and menstrual shedding occurs in the endometrium 
[9].   I t   i s   i m p o r t a n t   t o   m a i n t a i n   a   b alance between cell 
proliferation and cell death during the  dynamic  re-
modeling of tissue,  and  although  such  mechanisms 
have been extensively studied, they remain obscure. Int. J. Biol. Sci. 2011, 7 
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In the estrus cycle, Lcn-2   i s   f o u n d   i n  the uterus in high 
amounts  during  proestrus  and  estrus,  and  declines 
during metaestrus and diestrus [10]. Based on these 
data,  it  is  suggested  that  Lcn-2  secretion  is  closely 
a s s o c i a t e d   w i t h   t h e   c y c l e   o f   c e l l   p r o l i f e r a t i o n   a n d  
apoptosis during the remodeling of the endometrium. 
Additionally,  Lcn-2  is  an  acute-phase  protein 
[11, 12] expressed in several tissues and organs during 
inflammation in humans, mice and rats [13]. Expres-
sion of Lcn-2   i s   u p -regulated in response to inflam-
matory stimuli [11]. Lcn-2   i s   a l s o   u p -regulated in the 
uterus during pre-implantation and parturition and is 
b e l i e v e d   t o   b e   p a r t   o f   a   l o c a l   i n f l a m m a t o r y   r e s p o n s e  
associated with birth [10, 12]. Furthermore, Lcn-2 ex-
pression is induced by dexamethasone stimulation of 
the  endometrial  carcinoma  cell  line  (RL95-2)  [14]. 
Glucocorticoid   l e v e l s   a r e   h i g h e s t   d u r i n g   p r o e s t r u s  
when estrogen levels are highest [15]; glucocorticoid 
is designated as a stress hormone because its levels in 
circulation rise in response to stress and change  in 
response to specific physiological stimuli [16]. There-
fo r e ,   b a s e d   o n   g l u c o c o r t i c o i d   f l u c t u a t i o n   i n   t h e   e s t r u s  
cycle, Lcn-2 may be one of the stress molecules ex-
pressed in a stressed uterine microenvironment dur-
ing the estrus cycle. 
Our previous report [14] identified Lcn-2 as an 
apoptotic  factor  that  initiates  elevated  intracellular 
reactive oxygen species (ROS); triggers activation of 
caspase-8,  -9,  and  -3; and mediates endometrial car-
cinoma  cell  apoptosis.  Furthermore,  Lcn-2 binds  to, 
and is internalized by, RL95-2 cells but not HeLa cells, 
indicating cell specificity [14]. Lcn-2   p l a y s   a   d u a l   r o l e  
in microglia and is also associated with certain types 
of  cancer;  it t h u s   m a y   b e  involved in tumorigenesis 
[17,  18].  Taken  together,  these  results  suggest  that 
Lcn-2 may play a role in inflammation, cell prolifera-
tion and cellular apoptosis in different environments. 
As   w e   k n o w ,   c e l l   a p o p t o s i s   a n d   i n f l a m m a t o r y   r e-
sponse are closely interrelated. This raises the inter-
e s t i n g   q u e s t i o n   a s   t o   w h e t h e r   L c n -2   i s   s i m p l y   a n  
apoptotic factor, or whether it is perhaps involved in 
cytokine production. B a s e d   o n   p r e v i o u s   s t u d i e s ,   L c n -2 
has  diverse  physiological  functions,  implying  that 
Lcn-2 plays different roles in different environments. 
I t   e n c o u r a g e d   u s   t o   c l a r i f y   t h e   p o s s i b i l i t y   o f   L c n-2 
performing a dual role in regard to cells. 
This study aimed to clarify the relationship be-
tween Lcn-2 and cytokine expression in RL95-2 cells, 
and to investigate whether Lcn-2   i s   i n v o l v e d   i n   c y t o-
k i n e   p r o d u c t i o n .   I n   a d d i t i o n   t o   i t s   a p o p t o t i c   e f f e c t ,  
Lcn-2 may be a multifunctional lipocalin in endome-
trial carcinoma cell physiology. As inhibition of Lcn-2 
expression  impairs  breast  tumorigenesis  and  metas-
tasis [19]; this  protein  has been known to  affect cell 
migration  [20-22].   B a s e d   o n   o u r   p r e s e n t   d a t a ,  
Lcn-2–induced changes in the microenvironment may 
regulate  cell  migration.  The  over-expression  of  this 
protein  in vivo  m a y   t r i g g e r   c e l l   o v e r -growth,  which 
would lead to Lcn-2 being classified as a tumorigenic 
factor. 
 
Materials and methods 
Cell cultures and Lcn-2 treatment 
The human endometrial cell line   R L 9 5 -2 that was 
u s e d   i n   t h i s   s t u d y   w a s   o b t a i n e d   f r o m   American Type 
Culture Collection. The cells were grown in complete 
medium  containing  MEM  (Gibco,  CA,  US)  supple-
mented with 15% (v/v) heat-inactivated fetal bovine 
serum (FBS) (PAA, Pasching, Austria), 5 µg/ml insu-
lin  (Gibco),  100  U/ml  penicillin,  and  0.1  mg/ml 
streptomycin (Gibco). Cells (2 × 104 cells/well)  were 
cultured in complete medium with or without 10 µM 
Lcn-2 in a 48-well plate for the indicated time. After 
incubation, culture supernatants were collected and 
analyzed by Western blotting and cytokine array as-
says  (see  below).   M u r i n e   L c n -2  was  purified  from 
mouse uterine fluid. After purification, the purity  of 
Lcn-2 was confirmed via mass spectrometry analysis. 
Anti–mouse Lcn-2 antiserum was generated in rabbits 
as described [23]. 
Cell viability and proliferation assay 
RL95-2 cells were seeded into 96-well plates at a 
concentration of 1.0 × 104 cells/well. Cells were incu-
bated with complete medium in the absence or pres-
ence of 10 µM Lcn-2 and collected over the course of 
24-72 h.   A f t e r   i n c u b a t i o n ,   c e l l s   w e r e   w a s h e d   w i t h   s e-
rum-f r e e   m e d i u m   a n d   t e s t e d   f o r   m e t a b o l i c a l l y   a c t i v e  
cells using the redox dye resazurin using the Vision-
BlueTMQuick  Cell  Proliferation  Assay  Kit  (Catalog 
#K303-500, Biolinkk, New Delhi, India) .   U p o n   r e d u c-
tion  by  viable  metabolically  active  cells,  resazurin 
becomes highly fluorescent (λex = 545 nm; λem = 595 
n m ) .   T h e   n u m b e r   o f   p r oliferating  cells  was  deter-
mined by a cell counter (Invitrogen, CA, US). 
Preparation of cell lysates and Western blot 
analysis 
T h e   c o n d i t i o n e d   m e d i u m   f r o m   R L 9 5 -2 cells cul-
t u r e d   i n   t h e   a b s e n c e   o r   p r e s e n c e   o f   L c n -2   w a s   s u b-
jected  to  12%  SDS-PAGE  and  blotted  onto  a  PVDF 
membrane (PL-BSP0161, PALL, NY, US). Membranes 
w e r e   b l o c k e d   i n   b l o c k i n g   b u f f e r ,   c o n s i s t i n g   o f   5 %  
skim milk, 1× P B S ,   0 . 0 5 %   T w e e n   2 0   ( S i g m a , MO, US), 
and  incubated  with  anti-Lcn-2  rabbit  antibody 
(1:15,000).  Membranes  were  then  incubated  with 
secondary  anti–rabbit  IgG  (1:10,000).  Protein  bands Int. J. Biol. Sci. 2011, 7 
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were  visualized  using  an  enhanced  chemilumines-
cence kit (Millipore, WBKLS0050, MA, US) and X-ray 
film. 
RNA extraction, reverse transcriptase polyme-
rase chain reaction (RT-PCR) and quantitative 
real-time PCR (qPCR) 
Total RNA was  extracted  from  the  control and 
Lcn-2–treated  RL95-2 cells using an RNeasy Mini kit 
(Qiagen,  Hilden,  Germany) .   T h e   t o t a l   R N A   ( 5 0 0 ng) 
was reverse-t r a n s c r i b e d   i n   a   2 0 -µl volume using the 
MMLV reverse transcriptase kit (M6125H, epicenter, 
WI, US). qPCR and RT-PCR p r i m e r   p a i r s   u s e d   t o   t e s t  
for  IL-8,  IL-6,  MCP-1,  GRO,  Lcn-2  R,  LRP-2  and 
β-actin mRNA are listed in Table 1. To assess mRNA 
expression, qPCR and data analysis were performed 
using  7300  System  SDS  Software  (Applied  Biosys-
tems,   C A ,   U S) .   E x p r e s s i o n   o f   I L -8, IL-6, MCP-1, and 
G R O   m R N A   w a s   n o r m a l i z e d   f o r   e a c h   s a m p l e   u s i n g  
β-actin  mRNA  as  an  internal  standard.  PCR  condi-
tions were 40 cycles at 95°C for 15 s, 60°C for 30 s, and 
72°C for 1 min. Standardization of the data was per-
formed by subtracting the signal threshold cycles (CT) 
of the internal standard (β-actin) from the CT of IL-8, 
IL-6,  MCP-1 ,   a n d   G R O .   A l l   P C R   p r o d u c t   i d e n t i t i e s  
were sequenced and confirmed. Lcn-2 R and LRP-2 
were performed only for RT-PCR. 
Table 1: Primers for polymerase chain reaction 
  Primer Sequences 
Forward (5’-3’) Reverse (5’-3’) 
IL-8  ATgACTTCCAAgCTggCCgT  TCTCAgCCCTCTTCAAAAACTTCTC 
GRO  AATCCCCggCTCCTgCg  CCCATTCTTgAgTgTggCTATgA 
IL-6  ATCTggATTCAATgAggAgACTTgC  gCTCTggCTTgTTCCTCACTACTCT 
MCP-1  ACTgAAgCTCgCACTCTCgC  CTTgggTTgTggAgTgAgTgTTC 
aLcn-2 R  TgTgCTCACCACCAACgC  CCTCAATCTgCCgCTTCACT 
bLRP-2  gCCACCCACAgTgATAAgAgAC  ggCAgAgCAAAgCAgAgATgAg 
β-actin  gCACCAgggCgTgATgg  gCCTCggTCAgCAgCA 
a and b indicate two Lcn-2 receptors, respectively. 
 
 
Flow cytometry and fluorescence microscopy 
analysis of DNA damage 
Cells were incubated at 37°C  for  the  indicated 
t i m e ,   w a s h e d   w i t h   P B S ,   a n d   d e t a c h e d   b y   a d d i n g  
0.25% trypsin-EDTA (Gibco). Cells were resuspended 
in  400  µl MEM medium containing 2  µg/ml  propi-
dium  iodide  (PI;  Sigma,  P4170)  and  0.5  µg/ml 
FITC-labeled  annexin-V  (Sigma)  and  incubated  at 
ro o m   t e m p e r a t u r e   f o r   1 0   m i n   i n   t h e   d a r k .   F l o w   c y t o-
metry data were collected using a Coulter EPICS XL 
flow cytometer (Beckman-Coulter,  CA, US).  Fluores-
c e n c e   w a s   i n i t i a t e d   b y   e x c i t a t i o n   a t   4 8 8   n m   a n d   w a s  
measured  by  emission  filters  at  525  nm  (annexin 
V–FITC) a n d   6 2 5   n m   ( P I ) .   T o   e v a l u a t e   n u c l e a r   m o r-
p h o l o g y ,   c e l l s   w e r e   s t a i n e d   w i t h   2   µg / m l   o f   4 ’ ,  
6-diamidino-2-phenylindole (DAPI; Sigma) f o r   2   m i n  
to visualize DNA and were observed under a fluo-
rescence microscope (AH3-RFCA; Olympus). 
Analysis of caspase-3 activity using fluorescent 
peptide substrate 
Caspase-3  activity  was  determined  using  Phi-
PhiLux  G1D2,  a  fluorophore-labeled  caspase-specific 
substrate (OncoImmunin Inc., A304R1G-6, MD, US). 
T h e   m a i n   p e p t i d e   a m i n o   a c i d   s e q u e n c e   w a s   D E V D G I .  
Caspase-3 activity was measured by fluorescence in-
t e n s i t y .   C e l l s   w e r e   p l a c e d   i n   a   4 8 -well plate with dif-
ferent  treatments  and  incubated  with  50  µl   o f   s u b-
strate solution (10 µM PhiPhiLux G1D2 w i t h   1 0 %   F B S )  
for 1 h at 37°C. After washing with PBS, the cells were 
harvested  by  trypsinization  and  fluorescence  was 
measured using flow cytometry. 
Measurement of cytokine release using antibody 
arrays 
Cytokine release from RL95-2 cells was analyzed 
u s i n g   t h e   H u m a n   C y t o k i n e   A n t i b o d y   A r r a y   I   ( R a y-
Biotech,  H0108001,  GA,  US).  Conditioned  medium 
w a s   c o l l e c t e d   f r o m   R L 9 5 -2   c e l l s   t r e a t e d   w i t h   o r   w i t h-
out 10 µM  Lcn-2   i n   s e r u m -free medium for the indi-
cated time, centrifuged at  100×g f o r   5   m i n   a t   4 °C  to 
remove floating cells and debris, and stored at –20°C 
for further processing. The cytokine array membranes 
were blocked with blocking buffer ( provided by the 
Array kit) for 30 min and then incubated for 18 h with 
1   m l   c o n d i t i o n e d   m e d i u m   a t   4 °C. Membranes were 
then washed three times with PBST (PBS  containing 
0.5% Tween 20) at  room  temperature  with  shaking. 
T h e   m e m b r a n e s   w e r e   t h e n   i n c u b a t e d   w i t h   1   m l   b i o-
tin-conjugated anti-mouse IgG (1:20) for 3.5 h at room 
temperature  and  washed  as  described  above,  fol-
lowed  by  incubation  with  1  ml  HRP-conjugated 
streptavidin (1:1,000) for 1.75 h at room temperature. 
After a thorough wash, membranes were exposed to a Int. J. Biol. Sci. 2011, 7 
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peroxidase substrate (detection buffer C and D; Ray-
Biotech) for 1–2 min in the dark prior to imaging with 
X-ray film.  Signal  intensities  were quantified using 
Phoretix 2D v2004 software. 
Cell migration assay 
Cells grown in the logarithmic phase were har-
vested  and  resuspended  in  DMEM/F12  medium 
s u p p l e m e n t e d   w i t h   1 0 %   f e t a l   c a l f   s e r u m   ( FCS)   a t   a  
concentration of 2 × 105 cells/ml.  After  24-h incuba-
tion at 37°C, 100 µl of the cell suspension was placed 
into  the  upper  compartment  of 12-well plates,  with 
Transwell inserts.   S u b s e q u e n t l y ,   m e d i u m   i n   t h e   u p p e r  
compartment was supplemented with  400 µl   o f   c o n-
ditioned  medium  (CM)  that  had  been  collected  at 
different time intervals from Lcn2-treated RL95-2 cells 
after 24 to 48 h of incubation i n   t h e   p r e sence or ab-
sence  of  anti-IL-8.  Other  antibody  neutralizations, 
which  are  specific  to  each  cytokine,  were  also  per-
formed  individually. The lower compartments were 
filled  with  DMEM/F12  containing  10%  FCS,  and 
chambers were incubated at 37°C f o r   2 4   h .   T h e   f i l t e r s  
w e r e   g e n t l y   r i n s e d   w i t h   w a t e r ,   a n d   c e l l s   o n   t h e   u p p e r  
s u r f a c e   o f   t h e   f i l t e r s   w e r e   r e m o v e d   b y   w i p i n g   t h e  
surface with a cotton swab. The filters were then fixed 
w i t h   m e t h a n o l   f o r   1 0   m i n   a n d   s t a i n e d   w i t h   0 . 5 %  
crystal violet in 20% methanol for 20 min, followed by 
t w o   r i n s e s   w i t h   w a t e r .   C e l l s   o n   t h e   l o w e r   s u r f a c e   o f  
the membrane were observed and quantified using a 
light-inverted microscope at 20X magnification.  The 
n u m b e r   o f   c e l l s   t h a t   m i g r a t e d   t h r o u g h   t h e   i n s e r t   t o-
ward the bottom chamber was counted in ten random 
f i e l d s   u s i n g   p h a s e   c o n t r a s t   m i c r o s c o p y .   N e x t ,   t h e   f i l-
ters containing the stained cells were removed from 
the Transwell chambers and individually transferred 
to a separate well in a 96-well culture plate. The crys-
tal   v i o l e t   d y e   r e t a i n e d   o n   t h e   f i l t e r s   w a s   e x t r a c t e d   w i t h  
33% acetic acid (150 µl), and  the  absorbance  of  this 
solution  was  colorimetrically  measured  at  570  nm 
with an ELISA reader. 
Statistical analysis 
Statistical  analysis  was  conducted  using 
one-way  ANOVA  with  Dunnett’s  post  test  using 
GraphPad InStat version 3.00 for Windows (Graph-
Pad Software). 
 
Results 
Lcn-2 effects on RL95-2 cell morphology 
N u m e r o u s   c y t o k i n e s   a r e   a   p o t e n t   a c t i v a t o r   o f   c e l l  
survival [24] and are also involved in stress response. 
To assess possible effects of Lcn-2 on RL95-2 cells, we 
first observed the cell growth and then tested whether 
Lcn-2  could  play  the  dual  role:  apoptosis  and  cell 
survival, in these cells. Later, we desired to measure 
the  cytokine  secretions.  Fo r   t h i s   p u r p o s e ,   w e  pro-
longed the investigation of cell growth under Lcn-2 
incubation  (>  24h).  Using  the  10  µM  Lcn-2  supple-
mented culture conditions, we observed DNA  frag-
mentation and condensation as an indicator of apop-
tosis  via  microscopic  observation.  After  incubation 
with or without Lcn-2, cell nuclei were stained with 
DAPI and observed under a fluorescence microscope 
(Fig.  1A).  According  to  our  previous  experiment,  a 
high  level  of  serum  in  culture  media  would  delay 
RL95-2  cells’  response  to  Lcn-2  reaction  (data  not 
shown). To avoid the serum interference, we verified 
t h e   c e l l   g r o w t h   i n   t h e   m e d i a   w i t h   o r   w i t h o u t   s e r u m .  
The RL95-2 cells cultured under serum or serum-free 
media showed normally in nuclei during 72 h culture 
in this experiment (Fig. 1A, upper and middle panel, 
respectively). Thus, to avoid possible effects of serum, 
s u c h   a s   g r o w t h   f a c t o r s ,   serum-free medium was used 
for  subsequent  experiments.  Interestingly,  DNA 
fragmentation and condensation occurred after 24 h in 
the presence of Lcn-2 b u t   d e c l i n e d   b y   4 8   h   ( F i g .   1 A ,  
bottom panel; arrows). There was an increase in cell 
numbers  in  Lcn-2–treated  cultures  at  48  h  as  com-
pared with the cell number at Lcn-2-treated for 24 h 
(Fig.  2A).  It  indicated  that  the  cell  proliferation  re-
covered after 24 h later. The  cellular morphology of 
Lcn-2–treated  cells  differed  markedly  from  that  of 
untreated cells after 24 h   o f   c u l t u r e   ( F i g .   1 B ) .   C o n t r o l  
cells were round in shape and grouped together (Fig. 
1B).  At  this  time,  apoptotic  cells  appeared  in  Lcn-2 
treated cells, compared with the control cells. In addi-
tion, the control cells showed tight growth together 
and  Lcn-2–treated  cells  showed  separately  in  this 
moment (Fig. 1B). In   c o n t r a s t   t o   2 4   h ,   a f t e r   4 8   h , fewer 
apoptotic cells could be found and pseudopodia ap-
peared  in  Lcn-2–treated  cells.  This  coincided  with 
DNA staining data in Fig.1A. It is worth noting that at 
72 h incubation more detached cells appeared, indi-
cating  that  cell  migration  might  have  happened  or 
that cells may have died (Fig. 1B, arrows). I t   i s   p o s s i-
ble  that  the  lower  c e l l   n u m b e r   w a s   t h e   r e s u l t   o f   a  
shortage of nutrients in the serum-free medium in the 
72 h culture. Moreover, cell growth appeared to be 
restored after persistent incubation of cells in Lcn-2 
containing media f o r   > 2 4   h .   T o g e t h e r ,  these  results 
suggest  that  c e l l   a p o p t o s i s   s e e m e d   t o   s t a g n a t e; 
moreover, the cells kept  growing after persistent ex-
posure of cells in Lcn-2 for  mor e   t h a n   2 4 –48 h,  but 
detached after 48–72 h. To avoid cell growth in a nu-
trient-s h o r t   c o n d i t i o n ,   w e   p e r f o r m e d   o u r   l a t e r   e x p e-
riments within 48 h incubation as far as possible. Int. J. Biol. Sci. 2011, 7 
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Fig. 1: Lcn-2–induced DNA damage in and cell morphology of RL95-2 cells. RL95-2 cells were cultured on co-
verslips (1 × 10
5 cells/coverslip)   a n d   i n c u b a t e d   w i t h   o r   w i t h o u t   1 0   µM   L c n -2   f o r   2 4 –72 h; DNA damage was observed under 
a fluorescence microscope after DAPI staining. (A) Condensed and fragmented DNA is indicated with arrows. (B) Cell 
morphology of RL95-2 cells after incubation of cells with or without 10 µM Lcn-2 for 24, 48, and 72 h. Bar = 20 µm. 
 
 
 
Persistent Lcn-2 effects on RL95-2 cell prolifera-
tion and viability 
Fig. 2 A   s h o w s   t h e   c e l l   n u m b e r s   a f t e r   1 2 ,   2 4 ,   a n d  
4 8   h   o f   c u l t u r e   i n   a   m e d i u m   w i t h   o r   w i t h o u t   L c n -2 
(Fig. 2 A ,   b l a n k   b a r   o r   b l a c k   b a r ) .   I n   s e r u m -free me-
dium as a control, RL95-2 cells maintained persistent 
proliferation; the cell numbers were 5 ± 0.6 × 104, 5 ± 
0.4 × 104, and 1.04 ± 1.6 × 105 at 12, 24 and 48 h, re-
spectively  (Fig.  2A).  Thus,  these  cells  proliferated 
normally in serum-f r e e   m e d i u m   w i t h o u t   L c n -2 for 48 
h .   I n   t h e   p r e s e n c e   o f   L c n -2 ,   c e l l   n u m b e r s   d e c r e a s e d   t o  
54% (3.6 ± 0.2 × 104) at 24 h (P < 0.001), as compared 
with   t h e   c o n t r o l   c e l l s .   A f t e r   a   4 8  h  incubation  with 
Lcn-2, cell numbers did, however, increase to 73% (7.6 
± 1.5 × 104)   o f   t h e   c o n t r o l   ( P   <   0 . 0 5 ) ,   w h i c h   s u g g e s t s  
t h a t   c e l l   p r o l i f e r a t i o n ,   i n s t e a d   o f   c e l l   a p o p t o s i s ,   o c c u r s  
in the presence of persistent  Lcn-2.  Using the redox 
dye resazurin to analyze cell viability, we determined 
the percentage of viable cells in these cultures (Fig. 
2B). Proportional to the total number of cells, the via-
b l e   c o n t r o l   c e l l s   w e r e   a l m o s t   9 7 ±3% at 12 h culture. 
When RL95-2   c e l l s   w e r e   i n c u b a t e d   w i t h   L c n -2   f o r   2 4   h ,  
cell viability decreased to 55 ± 4.9%, as compared with 
85  ±  2.2% at 12 h; however, cell viability increased 
after  more  than  a  24-h  incubation,  and  was  main-
tained at 48 h (75 ± 6.8%). This pattern indicates that 
under  prolonged  Lcn-2  incubation,  the 
Lcn-2–resistant cells divided, which seems consistent 
with  the  reduction  in  apoptosis  seen  after  48  h  of 
Lcn-2 exposure (Fig. 1). Int. J. Biol. Sci. 2011, 7 
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Fig. 2: Cell proliferation and viability of RL95-2 cells 
after Lcn-2 treatment. RL95-2   c e l l s   ( 2   × 10
4 cells) were 
cultured for 36 h in complete medium and then cultured 
with or without 10 µM   L c n -2 for an additional 12, 24 and 48 
h. (A) Cell numbers. (B) Relative percentages of viable cells 
after Lcn-2   t r e a t m e n t   a s   c o m p a r e d   w i t h   u n t r e a ted control 
cells. The black bar indicates control cells; the blank bar 
indicates Lcn-2–treated  cells.  The  data  are  given  as  the 
mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001 as 
compared with the control (n ≥ 4). 
 
Caspase-3 activity in Lcn-2–treated RL95-2 cells 
Based on our previous results [14] and the above 
observations,  we  confirmed  that  Lnc-2  induced 
RL95-2  cell apoptosis under different culture media. 
Apoptosis was assessed by measuring the activity of 
the apoptotic enzyme caspase-3 in Lcn-2–treated cells. 
Caspase-3  activity,  relative  to  that  of  control  cells, 
increased in  a  dose-dependent manner after incuba-
tion  with  different  concentrations  of  Lcn-2 for 24 h 
(Fig. 3A). Even in serum-free medium, caspase-3 ac-
tivity increased insignificantly, and indicating normal 
cell growth. We used PI and annexin V–FITC double 
staining to measure c e l l   d e a t h   i n   t h e   p r e s e n c e   o f   5 μM 
Lcn-2   w i t h   o r   w i t h o u t   L c n -2  antibody.  Viable  cells 
increased from 76.3% to 91.5% in the presence of the 
Lcn-2 antibody (Fig. 3B). Thus the Lcn-2 antibody can 
neutralize the Lcn-2 reaction, and Lcn-2   m a y   p l a y   a  
specific role in RL95-2 cells. In addition, the caspase-3 
activity  of  Lcn-2–treated  cells  gradually  decreased 
(Fig. 3C, blank bar),   a s   c o m p a r e d   w i t h   c o n t r o l   v i a b l e  
cells (Fig. 3C, black bar; P<0.001). In 36 h incubation, 
caspase-3 activity was still at  a high level, compared 
with the control cells (P<0.01). At 48 h, the caspase-3 
activity of Lcn-2–treated cells had been markedly re-
duced  and  did  not  show  a  significant  difference  as 
compared with that of the control cells (P > 0.05), less 
caspase-3  activity  was  found,  compared  with  24  h 
Lcn-2–treated  cells  (P<0.001;  Fig.  3C).  The  result 
agrees with the observed increase in cell viability after 
persistent Lcn-2  exposure. Cell number and cell via-
bility determinations were performed after Lcn-2 ex-
posure f o r   4 8   h ,   a n d   i t   w a s   a s c e r t a i n e d   t h a t   t h e   r e d u c-
tion in caspase-3   a c t i v i t y   d i d   n o t   r e s u l t   f r o m   c e l l   l y s i s  
(Fig. 2).  During 48 h culture under serum-free  me-
dium,  the  caspase-3  activity  of  t h e   c o n t r o l   c e l l s   i n-
creased slightly, indicating less cell death via apopto-
sis. 
 
Confirming the persistence of Lcn-2 in culture 
The decrease in caspase-3 activity in RL95-2 cells 
m a y   h a v e   b e e n   c a u s e d   b y   d e g r a d a t i o n   o f   L c n -2  in 
culture.   T h u s ,   w e   h a r v e s t e d   t h e   s a m e   v o l u m e   o f   c o n-
ditioned medium from each treatment f o r   e a c h   o f   t h e  
incubation  times and  then  measured the  amount of 
Lcn-2   p r o t e i n   b y   Western blotting. In the serum-free 
conditioned media (Fig. 4, lanes 1–3), no Lcn-2  was 
o b s e r v e d   i n   t h e   2 4 ,   3 6   a n d   4 8  h   c u l t u r e s .   F o r   t h e  
Lcn-2–supplemented conditioned media (Fig. 4, lanes 
4–6), Lcn-2 was present in similar amounts across all 
three  time  points a n d   s h o w e d   l e s s   p r o t e i n   d e g r a d a-
tion, as compared with the 20ng purified Lcn-2 (Fig. 4, 
lane 7). Thus, neither the reduction in cell apoptosis 
nor the reduction in caspase-3 activity was caused by 
Lcn-2 degradation. 
 
Effects of persistent Lcn-2 on cytokine mRNA 
and protein levels in RL95-2 cells  
We next tested whether Lcn-2  stimulated  cyto-
kine production in RL95-2   c e l l s ,   g i v e n   t h a t   L c n -2 is an 
acute-phase protein. The culture media were collected 
from RL95-2 cells culture after incubation with 10 µM 
Lcn-2. A membrane-bound antibody array technique 
w a s   t h e n   u s e d   t o   c h a r a c t e r i z e   t h e   d i s t r i b u t i o n   o f   t r a c e  
cytokines  in  the  conditioned  media.  On  the  array 
membrane,  there  were  six  identical  positive  control 
antibodies and four negative controls (Fig. 5A).  Int. J. Biol. Sci. 2011, 7 
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Fig. 3: Effects of Lcn-2 on caspase-3 activity in RL95-2 cells. RL95-2 cells were cultured in 48-well plates (2 × 10
4 
cells/well)   w i t h   d i f f e r e n t   a m o u n t s   o f   L c n -2 for 24 h and then incubated with 50 µl   o f   caspase-3 substrate solution for 1 h at 
37°C .   ( A )   T h e   c l e a v e d   s u b s t r a t e   h a s   t h e   f o l l o w i n g   e x c i t a t i o n   a n d   e m i s s ion peaks: λex = 505 nm and λem = 530 nm. Cells were 
a n a l y z e d   b y   f l o w   c y t o m e t r y .   T h e   d a t a   a r e   e x p r e s s e d   a s   t h e   p e r c e n t a g e   o f   f l u o r e s c e n c e   i n t e n s i t y   a s   c o m p a r e d   w i t h   t h a t   o f   t h e  
control cells. (B) For cell apoptosis measurement, RL95-2 cells cultured for 24 h with 5 µM   L c n -2   i n  the absence or presence 
of 2.5 µM   a n t i -Lcn-2 .   C e l l s   w e r e   d o u b l e   s t a i n e d   w i t h   2 . 0   µg/ml annexin V–F I T C   a n d   1 . 0   µg / m l   P I   f o r   1 0   m i n   a n d   a n a l y z e d   b y  
flow cytometry. (C) C e l l s   w e r e   c u l t u r e d   a s   a b o v e   with 10 µM Lcn-2 for 24, 36 and 48 h, and then caspase-3 relative activity 
w e r e   m e a s u r e d .   T h e   b l a c k   b a r   i n d i c a t e s   c o n t r o l   c e l l s ,   a n d   t h e   b l a n k   b a r   i n d i c a t e s   L c n -2–treated cells. Data are expressed as 
the percentage of fluorescence intensity as compared with that of co n t r o l   c e l l s   a n d   a r e   p r e s e n t e d   a s   t h e   m e a n   ± SEM of 
multiple experiments (n ≥ 4). ***, P < 0.001. 
 
Fig. 4: Quantification of Lcn-2 in RL95-2–conditioned medium. RL95-2 cells were cultured with or without Lcn-2 
for the indicated times. Levels of Lcn-2 in conditioned media were determined by 12% SDS-PAGE and Western blotting with 
anti-Lcn-2 IgG. These data are representative of three independent experiments. (A) Lanes 1–3, conditioned media from 
RL95-2   c e l l s   c u l t u r e d   i n   s e r u m -f r e e   m e d i u m   f o r   2 4 ,   3 6   a n d   4 8   h ,  respectively; la n e s   4 –6 ,   c o n d i t i o n e d   m e d i u m   f r o m   R L 9 5 -2 
cells cultured with serum-free medium supplemented with 10 µM Lcn-2 for 24, 36 and 48 h, respectively; lane 7, 20ng of 
purified Lcn-2; la n e   8 ,   cell-free control consisting of an equivalent amount of Lcn-2–supplemented medium incubated for 48 
h at 37 °C without cells. F o r   l a n e   7 ,   L c n -2   w a s   l o a d e d   o n   t h e   g e l .  ( B )   m R N A   l e v e l s   o f   t w o   L c n -2   r e c e p t o r s ,   L R P -2   a n d   L c n -2R, 
were measured by RT-PCR analysis. Int. J. Biol. Sci. 2011, 7 
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Fig. 5: Cytokine array analysis of conditioned media   f r o m   L c n -2–treated RL95-2 cells. Conditioned medium 
was collected from RL95-2 cells treated with or without 10 µM Lcn-2 in serum-free medium for the indicated times. Cy-
tokine array membranes were incubated with 1 ml conditioned medium. (A) RayBio® Human Cytokine Antibody Array I 
Map. (B) The signals of cytokine concentrations in conditioned media; significant signals are labeled with Arabic numerals: 1, 
MCP-1 ;   2 ,   I L -6; 3, IL-8 ;   a n d   4 ,   G R O .   R e l a t i v e   i n t e n s i t i e s   o f   t h e s e   f o u r   c y t o k i n e s   a r e   s h o w n   i n   t h e   l o w e r panels with the 
intensities of values from control serum-f r e e   m e d i a   s e t   a s   1 .   ( C )   m R N A   l e v e l s   o f   c y t o k i n e s   i n   L c n -2–treated cells. A total of Int. J. Biol. Sci. 2011, 7 
 
http://www.biolsci.org 
82 
4 × 10
4 c e l l s   w e r e   i n c u b a t e d   w i t h   o r   w i t h o u t   1 0   µM   L c n -2 in serum-free medium for 24, 36 and 48 h. After incubation, total 
RNA isolated from cells was reverse transcribed and amplified by RT-P C R   u s i n g   p r i m e r s   f o r   M C P -1, IL-6, IL-8 and GRO. 
Levels of mRNA were determined by semi-quantitative RT-PCR. The data were calculated by subtracting the signal thre-
shold cycles ( C T )   o f   t h e   i n t e r n a l   c o n t r o l   ( β-a c t i n )   f r o m   t h e   C T   o f   M C P -1, IL-6, IL-8 and GRO, and then the relative ex-
p r e s s i o n   w a s   o b t a i n e d   b y   a   f o r m u l a   d e s c r i b e d   i n   t h e   M a t e r i a l s   a n d   Methods section.   V a l u e s   a r e   t h e   m e a n   ± SEM of multiple 
cultures (n ≥ 3). ***, P < 0.001. 
 
 
Fig. 5 B   d e p i c t s   t h e   r e s u l t s   o f   a   t y p i c a l   a s s a y   o f   a  
1-ml sample of conditioned medium using the array 
kit. Under these assay conditions, weak signals were 
detectable  in  serum-free  medium  (Fig.  5B,  upper 
panel); an intense signal was observed only for GRO, 
with far less-intense signals present for the other cy-
tokines. Four intense signals were detected in condi-
tion e d   m e d i a   c o l l e c t e d   f r o m   t h e   4 8   a n d   7 2   h  Lcn-2 
cultures: IL-8, IL-6, MCP-1 ,   a n d   G R O   ( Fig. 5A and B). 
Changes  in  cytokines  in  the  conditioned  medium 
shou l d   r e s u l t   f r o m   L c n -2–reacted  RL95-2 cells.  The 
e s t i m a t i o n   o f   t h e   c h a n g e   i n   t h e s e   c y t o k i n e s   w a s   b a s e d  
on the relative ratio to the serum-free medium at each 
time  interval,  using  a  non-linear  dynamic  analysis 
method  with  Phoretix  2D  software.  In  the 
Lcn-2–supplemented medium, the levels of IL-8, IL-6, 
MCP-1, and GRO were significantly increased 8.5-, 
45-, 6-,  and  2-fold, respectively, at 48 h (Fig. 5B, bot-
tom  panel)  as  compared  with  those  of  the  control 
m e d i u m .   A t   2 4   h ,   i n c r e a s e s   i n   the expression of these 
four cytokines may not be sufficient to rescue the cells 
under  apoptotic  progression.  The  cell  detachment 
( F i g .   1 B )   o r   n u t r i e n t   s h o r t a g e   a t   7 2   h   m i g h t   c a u s e   l e s s  
cytokine  secretion,  and  then  we  were  unable  to 
measure the cytokines at high levels. Fo r   t h i s   r eason, 
w e   u s e d   t h e   4 8   h   c o n d i t i o n a l   m e d i a   f o r   the later  ex-
periments.  Although  the  data  obtained  were  not 
quantitative,   t h e y   w e r e   u s e d   t o   o b t a i n   a   r o u g h   e s t i-
mate  of  the  changes  in  some  detectable  cytokines. 
Even though the fold increase in IL-6 was high, it was 
s e c r e t e d   a t   a   l o w   b a s a l   l e v e l   i n   t h e   c o n d i t i o n e d   m e-
d i u m .   T h e   m R N A   l e v e l s   o f   t h e   f o u r   c y t o k i n e s   w e r e  
detected  using  semi-quantitative  RT-P C R .   T h e   e x-
pression levels were normalized to β-actin.  The  rela-
tive mRNA levels of Lcn-2–treated cells, divided by 
the  levels  in  the  control  cells,  equaled  the  fold  in-
creases  (Fig.  5C).  In  Lcn-2–treated  cells,  the  mRNA 
levels of these four cytokines increased less as com-
pared with those in the control cells, with the excep-
tion of IL-8 (P < 0.001). The relative expression mRNA 
levels  of  MCP-1 ,   G R O   a n d   I L -6  increased  to  4.28±
1.18,  2.16±0.41  and  6.38±0.31,  respectively,  com-
pared  t o   t h e   c o n t r o l   c e l l s   a t   4 8   h .   In  this  respect, 
m R N A   d a t a   d i d   c o i n c i d e   w i t h   t h e   d a t a   f r o m   t h e   c y-
tokine array. Possibly, this technique could not accu-
r a t e l y   m e a s u r e   t h e   s m a l l   a m o u n t   o f   t h e   i n c r e a s e ,   o r  
these genes were only at a lower basal level. Only the 
expression and secretion of IL-8 that showed a signif-
icant increase at 48 h are easier to detect. IL-8 may act 
as an autocrine growth factor in endometrial stromal 
cells [25]. Thus, the secretion of IL-8   m a y   b e   i n v o l v e d  
in the reduction in Lcn-2–induced cell apoptosis. To 
determine  the  IL-8  effect  on  Lcn-2–treated  RL95-2 
cells was our major focus. 
Interleukin-8 suppressed Lcn-2–induced apopto-
sis and improved cell survival 
IL-8 expression is significantly increased in late 
secretory  and  early-to-middle  proliferative  phases 
d u r i n g   t h e   m e n s t r u a l   c y c l e   [ 26]   a n d   m a y   b e   i n v o l v e d  
in the growth and proliferation of the endometrium, 
not only by indirectly stimulating  leukocytes  to  se-
crete growth factors and cytokines but also by directly 
stimulating endometrial cell proliferation [25].  Inte-
restingly, Lcn-2 gene expression and protein secretion 
a r e   p r e s e n t   i n   t h e   p r o l i f e r a t i v e   p h a s e   o f   t h e   m o u s e  
proestrus stage [10];  its presence may correlate with 
cytokine secretion during this period. Based on these 
findings  a n d   o u r   d a t a ,   w e   hypothesized  that 
Lcn-2–induced IL-8 secretion from RL95-2 cells may 
c o r r e l a t e   w i t h   c e l l   a p o p t o s i s   s u p p r e s s i o n .   T o   a s s e s s  
the possible effects of IL-8   o n   L c n -2–induced RL95-2 
cell apoptosis, we analyzed the caspase-3 activity of 
Lcn-2–treated RL95-2 cells in the presence of IL-8 (Fig. 
6A). Because cytokines are active at picomolar levels, 
IL-8  at  picomolar  concentrations  was  used  to  deter-
mine  the  effect  of  IL-8  on  RL95-2   c e l l s .   T h e   d a t a  
showed  no  difference  in  the  caspase-3  activity  of 
RL95-2   c e l l s   c u l t u r e d   w i t h   2 0   n g   r I L -8 in the absence 
of  Lcn-2  for  36  h.  rIL-8  did,  however,  reduce 
Lcn-2–induced  caspase-3  activity  ~20%  (from  290  ± 
46.1% in control cells to 240 ± 22.5% in rIL-8–treated 
c e l l s ;   P   <   0 . 0 5 ) ,   a s   c o m p a r e d   w i t h   t h e   c e l l s   i n c u b a t e d  
with Lcn-2 alone (Fig. 6A). 
Furthermore, the neutralizing effect of IL-8  an-
tibody on Lcn-2–induced apoptosis was investigated. 
In the IL8 neutralizing antibody experiment, the cas-
pase-3 activity of cells incubated with Lcn-2   a n d   I L -8 
antibody for 48 h was significantly increased by ~35% 
(from 355 ± 18.6% in the control cells to 462 ± 27.4%; P 
<   0 . 0 0 1 ) ,   a s   c o m p a r e d   w i t h   L c n -2  protein  treatment Int. J. Biol. Sci. 2011, 7 
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only (Fig. 6B). Removing the endogenous IL-8 mole-
cule diminished cell protection from Lcn-2–induced 
apoptosis. Incubating the cell along with IL-8 antibo-
d y   d i d   n o t   t r i g g e r   c e l l u l a r   c a s p a s e -3 activity, which is 
notably  different  from  its  effects  in  control  cells.  It 
see m s   r e a s o n a b l e   t o   s u g g e s t   t h a t ,   w h e n   L c n -2 is sup-
p l i e d   f o r   4 8   h ,   I L -8 mRNA increases markedly  (Fig. 
5C). These data suggest that secreted IL-8, which was 
induced  by  Lcn-2,  suppressed  Lcn-2–induced  cell 
apoptosis  significantly.  Therefore,  inhibition  of 
Lcn-2–i n d u c e d   c e l l   a p o p t o s i s   m a y   b e   m e d i a t e d   b y   a n  
IL-8 signal transduction pathway. 
Effects of Lcn-2–stimulated RL95-2–conditioned 
medium on RL95-2 cell migration 
 A c c o r d i n g   t o   t h e   d a t a   o f   F i g . 1B,  the detached 
cells  appeared  during  48–72  h  incubation,  the  de-
tachment may correlate with cell migration. Lee et al. 
[27] stated that IL-8   p r o d u c t i o n   m a y   r e g u l a t e   c e l l   p r o-
liferation, survival  and migration. Furthermore,  we 
wanted to evaluate whether Lcn-2   w a s   a b l e   t o   i n d u c e  
IL-8 to promote cell migration. Because previous stu-
dies have suggested that IL-8 is involved in cell pro-
liferation and survival, we used a transwell chemo-
t a x i s   a s s a y   t o   a d d r e s s   w h e t h e r   t h e   c o n d i t i o n e d   m e d i a  
that  contained  IL-8  affect  cell  migration  of  RL95-2 
cells. Because  of the slow movement of RL95-2 cells, 
o u r   t r a n s w e l l   c e l l   m i g r a t i o n   a s s a y s   w e r e   p e r f o r m e d  
by following the method o f   U c h i d a   e t   a l .   [ 2 8 ] ,  with 
migration  allowed  for  24  h.  Migration  was  deter-
m i n e d   b y   t h e   m e a n   n u m b e r   o f   R L 9 5 -2 cells that mi-
grated from the upper to the lower chamber (Fig. 7A). 
Conditioned media from cultures that had been in-
cubated with Lcn-2 for 48 h increased RL95-2   c e l l   m i-
gration significantly (P < 0.01). Because Lcn-2 is in-
duced  under  serum-free  medium  [14] ,   w e   a s s u m e d  
that  IL-8   s h o u l d   a l s o   b e   i n d u c e d   u n d e r   s u c h   c o ndi-
tions. Furthermore, we measured the cell migration 
under serum-f r e e   m e d i u m   w i t h   o r   w i t h o u t   I L -8 anti-
body. As expected, elimination of IL-8   f r o m   t h e   m e-
dium  suppressed  cell  migration  from  the  upper 
c o m p a r t m e n t   t o   t h e   l o w e r   c o m p a r t m e n t   ( F i g .   7 B ;   P   <  
0.001).  T h e s e   d a t a   i n d i c a t e   t h a t   L c n -2–induced  IL-8 
could promote the cell migration. The data shown in 
Fig. 5B i s   b a s e d   o n  four cytokines elevated in Lcn-2 
conditional media. Determining whether  all  of  these 
cytokines correlate with cell migration was also our 
concern.  Af t e r   n e u t r a l i z a t i o n   o f   e a c h   c y t o k i n e   v i a   a 
specific antibody in 48 h conditional media (48hrCM), 
w e   m e a s u r e d   t h e   c e l l   m i g r a t i o n   v i a   t r a n s w e l l   a s s a y s  
for  24  h.  Actually,  the  specific  antibodies  of  GRO, 
MCP-1   a n d   I L -6 in conditional media did not show 
the correlation with cell migration significantly, even 
in  high d o s e s   o f   t h e s e   a n t i b o d i e s   ( d a t a   n o t   s h o w n ) .  
The IL-6 antibody neutralization assay as representa-
t i v e   d a t a   w a s   p r e s e n t   i n   F i g . 7B (P>0.05). It indicated 
that IL-8   p r o d u c t i o n   f o r   c e l l   m i g r a t ion  is  of  vital im-
portance. 
 
 
 
 
 
 
 
 
Fig.  6:  Effects  of  IL-8  on  caspase-3  activity  in 
Lcn-2–treated  RL95-2  cells.  (A) Exogenous rIL-8 (20 
n g )   w a s   a d d e d   t o   L c n -2–treated RL95-2   c e l l s .   ( B )   I L -8 an-
tibody  neutralizing  assay.  Caspase-3  activities  of  RL95-2 
cells were treated with or without IL-8 antibody for the 
time period indicated. Cells were then harvested, and en-
zyme activity was assayed and measured by flow cytometry. 
24 h, black bars; 36 h, gray bars; and 48 h, blank bars. The 
cleaved substrate has the following excitation and emission 
peaks: λex =   5 0 5   n m   a n d   λem =   5 3 0   n m .   V a l u e s   a r e   t h e   m e a n  
± SEM. *, P < 0.05; ***, P < 0.001 (n ≥ 4). Int. J. Biol. Sci. 2011, 7 
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Fig.  7:  Effects  of  Lcn-2–conditioned  medium  on 
RL95-2 cell migration. RL95-2 cells (8 × 10
4) were sti-
mulated with 10 µM Lcn-2   f o r   v a r y i n g   l e n g t h s   o f   t i m e ,   a n d  
then culture supernatants were collected from conditioned 
medium. Cytokine antibodies (anti-IL-8 or anti-IL-6) were 
added  to  clarify  the  effect  of  these  cytokines  on 
48hrCM-induced cell migration. Cell migration was meas-
ured using the transwell assay in the absence or presence of 
conditioned medium. (A) After incubation f o r   2 4   h ,   R L 9 5 -2 
cells were stained with 0.5% crystal violet, and cells were 
c o u n t e d   i n   t e n   r a n d o m   f i e l d s   u n d e r   a   m i c r o s c o p e   a t   2 0 × 
magnification. (B) OD570 v a l u e s   o f   c e l l s   o n   t h e   lower surface 
o f   t h e   m e m b r a n e   e x t r a c t e d   w i t h   3 3 %   a c e t i c   a c i d   a f t e r   a n-
ti-IL-8 neutralization. These data are representative of three 
independent experiments. The cell number of RL95-2 in-
cubation under 48hrCM for 24h is as a control experiment. 
Values are the mean ± SEM. **, P < 0.01; ***, P < 0.001. 
 
 
 
Discussion  
In  RL95-2   c e l l s ,   a p o p t o s i s   i s   i n d u c e d   b y   L c n -2 
within 24 h of culture [14]. This study evaluated Lcn-2 
effects  using  exogenous  Lcn-2  protein,  which  was 
purified  from  mouse  uterine  fluid,  and  suggested 
that, in the presence of Lcn-2, apoptosis may be sup-
pressed and result in improved cell survival. When 
cells  die  in  vivo,  they  trigger  an  inflammatory  re-
s p o n s e   l e a d i n g   t o   t h e   r e l e a s e   o f   a   n u m b e r   o f   m o l e c u l e s  
that  serve  as  defense  and  repair  mechanisms,  and 
thus  the inflammatory response may play a role in 
l i m i t i n g   f u r t h e r   d a m a g e   t o   t h e   c e l l s .   A s   a n  
acute-phase  protein,  Lcn-2  may  activate  such  a  cell 
defense system after the induction of cell apoptosis, 
v i a   t r i g g e r i n g   t h e   e x p r e s s i o n   o f   p r o -inflammatory 
molecules. Numerous reports mention that Lcn-2, as a 
multifunctional lipocalin in mammals, may play a role 
as a stress-induced protein that elicits cytokine secre-
tion [29-32] .   E x p o s u r e   o f   c e l l s   t o   s t r e s s   r e s u l t s   i n   t h e  
g e n e r a t i o n   o f   R O S   a n d   t h e   p r o d u c t i o n   o f   c y t o k i n e s  
such  as  IL-8,  which  implies  that  cytokine  secretion 
could be related to intracellular ROS elevation. Fur-
thermore, Lcn-2   e l e v a t e s   i n t r a c e l l u l a r   R O S   a f t e r   i n t e-
racting  with  RL95-2  cells  [14],  suggesting  that  the 
stimulation of cytokine secretion would be responsive 
t o   R O S   e l e v a t i o n   [ 33,  34].  The  data  in  this  current 
s t u d y   s h o w   t h a t   t h e   p r o d u c t i o n   o f   a t   l e a s t   f o u r   c y t o-
kines increased after 48 h of culture in the presence of 
Lcn-2.  IL-8  mRNA  expression  showed  the  most 
p r o m i n e n t   i n c r e a s e   a m o n g   t h e   f o u r   c y t o k i n e s   m eas-
ured and was associated with diminished caspase-3 
activity  and  apoptosis  in  RL95-2  cells  (data  not 
shown). 
I n   m i c e ,   I L -8–like molecules are highly expressed 
i n   t h e   u t e r u s   a t   t h e   late  proestrus  and  early  estrus 
s t a g e s   i n   a s s o c i a t i o n   w i t h   L c n -2  gene  expression 
( u n p u b l i s h e d   d a t a ) .   T h e s e   d a t a   s u g g e s t   t h a t   a   r e l a-
tionship  between  Lcn-2  and  IL-8   e x i s t s   d u r i n g   t h e  
endometrial cycle. In fact, rIL-8 was  associated  with Int. J. Biol. Sci. 2011, 7 
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reduced  Lcn-2–induced apoptosis and caspase-3 ac-
tivity ( n e a r l y   5 1 % ,   a s   c o m p a r e d   w i t h   t h e   a b s e n c e  of 
IL-8   i n   t h e   m e d i u m ) .   T h i s   r e s u l t   m a y   r e v e a l   t h e   p o s-
sibility of an association between Lcn-2   a n d   I L -8 dur-
ing the menstrual c y c l e .   I n   t h e   c u r r e n t   s t u d y ,   w e   c o u l d  
not, however, obtain a more significant reduction in 
caspase-3 activity induced by cell apoptosis to reach a 
notable  level  of  decrease. This implies that IL-8 may 
not be a unique factor for cell rescue. In any case, the 
antibody-neutralizing  experiment  emphasized  that 
endogenous IL-8   a c t s   a s   a   c e l l   s u r v i v a l   f a c t o r   a n d   t h a t  
its antibody can  block  its function. The possibility of 
o t h e r   c y t o k i n e s   i n d u c e d   b y   L c n -2  that  might  be  in-
volved in the suppression of apoptosis and improved 
cell survival were also o f   c o n c e r n   t o   u s .   I t   s u g g e s t e d  
that IL-8 did play an important role in cell survival, 
and that IL-8   s i g n a l   t r a n s d u c t i o n   m a y   b e   o n e   o f   t h e  
mediators to prevent the Lcn-2–induced cell apopto-
sis.  IL-8  directly  enhances  endothelial  cell  prolifera-
t i o n ,   s u r v i v a l   a n d   M M P   e x p r e s s i o n   [ 27]. This result 
suggests that cytokines, s u c h   a s   I L -8, may affect other 
cell functions, such as cell migration. Here we found 
that cell migration was increased in RL95-2 cells that 
were  treated  with  supernatants  from  cultures  of 
Lcn-2–stimulated  RL95-2  cells.  Our  results  are  con-
sistent with previous studies that demonstrated that 
Lcn-2 is expressed during apoptosis [30, 35] and that it 
has dual functions, including apoptosis and cell sur-
vival [29]. I n   t h e   c a s e   o f   IL-6, MCP-1 and GRO, secre-
tion from Lcn-2–treated RL95-2  cells,   e a c h   o f   t h e   c y-
tokines might act as a potent force for cell migration 
[36, 37].  In  the antibody neutralization assay, the re-
sults revealed that the elimination of the IL-6, MCP-1 
a n d   G R O   f r o m   t h e   L c n -2-4 8 h r C M   c o u l d   n o t   a f f e c t   t h e  
cell migration. Du e   t o   t h e   e x p r e s s i o n   o f   I L -6, MCP-1 
and GRO at a low level following cell apoptosis, we 
hypothesized that they may act together in having a 
synergetic effect on cell survival rather than on  cell 
m i g r a t i o n .   T h a t   i s   t o   s a y ,   t h e   m u t u a l   i n f l u e n c e   b e-
tween  each  cytokine  is  essential  for  regulating  the 
physiological  function  of  Lcn-2-treated-cells  [38]. 
Fu r t h e r   e v i d e n c e   i s   n e c e s s a r y   t o   c o n f i r m   t h i s  compli-
cated relationship. 
Herein,  Lcn-2  was  characterized  as  a 
bi-functional molecule that plays a role in apoptosis 
and survival in endometrial carcinoma cells. Perhaps 
Lcn-2 funct i o n s   v i a   a   d i f f e r e n t   p a t h w a y   t o   t r i g g e r   c e l l  
death  and/or  cell survival at different times or via 
different  Lcn-2  receptors.  Alternatively,  some  un-
known  m o l e c u l e s   m a y   h a v e   b e e n   e l i c i t e d   i n  
Lcn-2–induced apoptotic cells that then triggered cy-
tokine secretion during apoptosis. Lcn-2 induces the 
epithelial-to-mesenchymal transition in breast cancer 
c e l l s   a n d   p r o m o t e s   i n v a s i o n   [ 39], which implies that 
Lcn-2–induced cell survival may play a role in tumo-
rigenesis.  Recently,  Lcn-2  expression has  been used 
for the early diagnosis of pancreatic and other cancers 
[40-42].  Together,  these  findings  reveal  the  impor-
tance of Lcn-2 and its biological significance. 
In summary, this report is the first to show that 
t h e   s u p p r e s s i o n   o f   L c n -2–induced apoptosis resulted 
in  increased  cytokines  secretion  and  cell  migration. 
We  suggest  that  Lcn-2–induced  cytokines  secretion 
may improve cell survival functions. As it is a known 
cancer marker, Lcn-2   m a y   i n d i r e c t l y   c o r r e l a t e   w i t h   t h e  
pathogenesis of uterine diseases, such as uterine tu-
morigenesis mediated by IL-8 secretion. We inferred 
that  over-expression  of  Lcn-2   i n   t h e   u t e r u s   m a y   b e  
related to uterine cancer formation via the increased 
expression of inflammatory molecules. Clearly, more 
studies  are  needed  to  further  understand  possible 
roles for Lcn-2 in tumorigenesis in the female repro-
ductive system. 
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